Kromosol

Roman name

Cromosol

The composition and the form of

one dose spray for intranasal application contains kromoglikata sodium 2.6 mg; Patients in the unit to 28 ml of 2% solution (an average of 190 doses), in a cardboard bundle one bottle.

Pharmacokinetics

After intranaznalnogo of about 7% sodium kromoglikata absorbed and quickly return with urine and jelchew in an unmodified form. The rest of the product is from the nose during expiration or displayed by the digestive tract after swallowing. Linking plasma protein is 65%. Do not metabolised in the body. T1/2 of 1.5 p

Farmakodinamika

Stops early and late phase allergic reactions. Ters symptoms thereof.

Indications

Allergic rhinitis (prevention and treatment).

Pregnancy and lactation

With caution. At the time of treatment should stop breastfeeding.

Contraindications

Hypersensitivity, the children's age (up to 2 years).

Specific guidance

The caution shall mean the kidney and / or liver failure.

Patient interaction

Prescribed drug interaction Kromosol not described.

Overdosing

So far, cases of drug overdose Kromosol were reported.

Precautions

Be wary encouraged to nominate patients with kidney or liver failure.

Storage conditions

In the dark place at room temperature

Shelf life

3 years

The registration

013813/01-2002

Directory → Интермедианты → Gistaminergicakie funds → Gistaminolitiki → Stabilisers membranes fat cells → Kromosol